Immunogenic composition containing rabbit staphylococcus antigen, preparation method and application thereof
A staphylococcal and immunogenic technology, applied in the field of veterinary biological products, can solve the problems of vaccine strain failure, storage space occupation, and reduced protection rate, and achieve the effects of easy storage, high porosity, and guaranteed firmness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] (1) Preparation of Rabbit Staphylococcus Antigen Strain
[0030] 1) The intestinal bacteria and respiratory bacteria isolated and cultured from the liver and lung of the dead rabbit infected with Staphylococcus aureus were used for recovery as strains. After passing the pure bacteria inspection, the two strains were inoculated into ordinary broth medium respectively. Incubate at 37°C for 20h to prepare bacterial liquid with a predetermined concentration;
[0031] 2) Using turbidimetry and ultraviolet spectrophotometry to determine the concentration of respiratory bacteria to be 300 million / mL, add formaldehyde solution according to 0.3% of the bacterial liquid volume, and inactivate at 37°C for 20h; determine the concentration of intestinal bacteria to be 1 billion / mL mL, first bathed at 100°C for 2.5h, then added 0.3% formaldehyde solution and inactivated at 37°C for 20h;
[0032] 3) Inoculate the intestinal bacteria and respiratory bacteria treated in step 2) on a co...
Embodiment 2
[0043] This embodiment is basically the same as Embodiment 1, except that:
[0044] The dispersing carrier in this embodiment is chitosan nanoparticles loaded with disperse protein B, which can promote the overall diffusion of the biofilm and is conducive to the dispersion and release of the antigenic strains of Staphylococcus rabbits.
[0045] The preparation method of the dispersion carrier is as follows: adding dispersin B solution to a chitosan acetic acid solution with a concentration of 4.0 mg / ml until the final concentration of dispersin B is 2.0 mg / ml, at 30-35° C. and under the condition of magnetic stirring Mix well, let stand at 25°C for 22h, and add phosphate ester with a final concentration of 1.5mg / ml under the condition of low-speed magnetic stirring at 200rpm to activate the chitosan nanoparticle, which is convenient for loading disperse protein B, and keep stirring for 35min. The obtained chitosan nanoparticles loaded with disperse protein B have the character...
Embodiment 3
[0051] This embodiment is basically the same as Embodiment 2, except that:
[0052] The water-based printing adjuvant in this example adopts the commercially available Montanide TM Gel's aqueous vaccine adjuvant.
PUM
Property | Measurement | Unit |
---|---|---|
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com